Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006212
Filing Date
2018-08-02
Accepted
2018-08-02 16:06:43
Documents
72
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20180630x10q.htm 10-Q 1514096
2 EX-3.1 idra-20180630ex3192383c1.htm EX-3.1 880842
3 EX-10.1 idra-20180630ex101f7f3f1.htm EX-10.1 416895
4 EX-31.1 idra-20180630ex311e46a14.htm EX-31.1 18370
5 EX-31.2 idra-20180630ex3125b06f5.htm EX-31.2 18295
6 EX-32.1 idra-20180630ex3214e073a.htm EX-32.1 7932
7 EX-32.2 idra-20180630ex322b3315d.htm EX-32.2 7732
8 GRAPHIC idra20180630ex3192383c1001.jpg GRAPHIC 5637
9 GRAPHIC idra20180630x10q001.jpg GRAPHIC 14972
10 GRAPHIC idra20180630x10q002.jpg GRAPHIC 3116
11 GRAPHIC idra20180630x10q003.jpg GRAPHIC 8010
12 GRAPHIC idra20180630x10q004.jpg GRAPHIC 7572
13 GRAPHIC idra20180630x10q005.jpg GRAPHIC 4183
14 GRAPHIC idra20180630x10q006.jpg GRAPHIC 7470
  Complete submission text file 0001558370-18-006212.txt   7039609

Data Files

Seq Description Document Type Size
15 EX-101.INS idra-20180630.xml EX-101.INS 1259819
16 EX-101.SCH idra-20180630.xsd EX-101.SCH 43046
17 EX-101.CAL idra-20180630_cal.xml EX-101.CAL 34418
18 EX-101.DEF idra-20180630_def.xml EX-101.DEF 128689
19 EX-101.LAB idra-20180630_lab.xml EX-101.LAB 317836
20 EX-101.PRE idra-20180630_pre.xml EX-101.PRE 259957
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 18988282
SIC: 2836 Biological Products, (No Diagnostic Substances)